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Abstract
Background Temperature management is used with increased
frequency as a tool to mitigate neurological injury. Although
frequently used, little is known about the optimal cooling
methods for inducing and maintaining controlled normo- and
hypothermia in the intensive care unit (ICU). In this study we
compared the efficacy of several commercially available cooling
devices for temperature management in ICU patients with
various types of neurological injury.
Methods Fifty adult ICU patients with an indication for
controlled mild hypothermia or strict normothermia were
prospectively enrolled. Ten patients in each group were
assigned in consecutive order to conventional cooling (that is,
rapid infusion of 30 ml/kg cold fluids, ice and/or coldpacks),
cooling with water circulating blankets, air circulating blankets,
water circulating gel-coated pads and an intravascular heat
exchange system. In all patients the speed of cooling (expressed
as°C/h) was measured. After the target temperature was
reached, we measured the percentage of time the patient's
temperature was 0.2°C below or above the target range. Rates
of temperature decline over time were analyzed with one-way
analysis of variance. Differences between groups were analyzed
with one-way analysis of variance, with Bonferroni correction for
multiple comparisons. A p < 0.05 was considered statistically
significant.
Results Temperature decline was significantly higher with the
water-circulating blankets (1.33 ± 0.63°C/h), gel-pads (1.04 ±
0.14°C/h) and intravascular cooling (1.46 ± 0.42°C/h)
compared to conventional cooling (0.31 ± 0.23°C/h) and the
air-circulating blankets (0.18 ± 0.2°C/h) (p < 0.01). After the
target temperature was reached, the intravascular cooling
device was 11.2 ± 18.7% of the time out of range, which was
significantly less compared to all other methods.
Conclusion Cooling with water-circulating blankets, gel-pads
and intravascular cooling is more efficient compared to
conventional cooling and air-circulating blankets. The
intravascular cooling system is most reliable to maintain a stable
temperature.
Introduction
Temperature management is used with increasing frequency
as a tool to mitigate neurological injury. Mild hypothermia has
a beneficial effect on outcome in patients after out of hospital
cardiac arrest [1-3]. Hypothermia also effectively lowers
intracranial pressure in patients after traumatic brain injury [4-
6] and was found to lower mortality in subgroups of patients
[7]. In a Cochrane analysis, however, no overall benefit in
terms of lower morbidity or mortality could be determined [8].
Fever is extremely common in brain-injured patients. The risk
increases with the length of ICU stay from 16% for patients
admitted to a neurological intensive care unit (ICU) for less
than 24 hours to 93% for those staying longer than 14 days
[9]. Hyperthermia exacerbates ischemic neuronal injury in
patients at risk of secondary brain damage [10].
Temperature reduction is neither easy nor without risk. Induc-
tion of hypothermia can result in decreased cardiac output,
arrhythmias, bleeding diathesis, electrolyte disorders and
increased insulin resistance [11]. To be applicable in a larger
number of patients, cooling has to be accomplished in an
easy, controllable, minimally invasive and well-tolerated way.
Little is known about the optimal method of temperature con-
trol. Most studies have compared a single cooling technique
with medical treatment or another cooling device. The aim of
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this study is to compare five different cooling techniques dur-
ing induction and maintaining of mild hypo- and normothermia
in terms of efficiency and cooling performance.
Materials and methods
Study population
A total of 50 consecutive adult patients with an indication for
controlled mild hypothermia or strict normothermia were pro-
spectively enrolled. The local Institutional Review Board
waived the need for informed consent. The target temperature
in the mild hypothermia group was a rectal temperature of
33°C, and in the strict normothermia group the target temper-
ature was a rectal temperature of 37°C.
The study was conducted in the ICU of a tertiary university
hospital. Patients were eligible for induction of normothermia if
they developed a temperature of >38.5°C for at least 30 min-
utes. The ICU medical staff identified the patients that required
cooling to hypo- or normothermia.
Patients were excluded from the study if they had a rectal tem-
perature <34.5°C (in the hypothermia group) or <38.5°C (in
the normothermia group) at the beginning of the study. In addi-
tion, patients were excluded if they suffered from severe hemo-
dynamic instability, severe sepsis, or active bleeding or if they
received renal replacement therapy. Severe hemodynamic
instability was defined as the need for increasing amounts of
vasoactive support, or requiring >0.5 μg/kg/minute
(nor)epinephrine. Severe sepsis was defined as sepsis with
organ dysfunction/failure. Active bleeding was defined as
blood loss requiring more than 2 units of erythrocyte concen-
trates/24 hours.
Study intervention
Ten patients in each group were prospectively assigned to
conventional cooling, cooling with a water circulating external
cooling device (Blanketrol II, Cincinatti Subzero, The Surgical
Company, Amersfoort, The Netherlands), an air circulating
external cooling device (Caircooler CC1000, Medeco, Oud-
Beijerland, The Netherlands), a water circulating external cool-
ing device using self-adhesive gel-coated pads (Arctic Sun,
Medivance, Jugenheim, Germany) or an intravascular heat
exchange system (Icy-catheter, Alsius Coolgard 3000, Medi-
cor, Nieuwegein, The Netherlands). Randomization was done
by assignment of the patients in consecutive order to the dif-
ferent devices. Following identification by the medical staff, the
patients were included in the study and allocated to a cooling
method. The order of the cooling devices was determined ran-
domly and not influenced by the clinicians responsible for the
individual patients. During the test period of a specific device,
no patient was cooled using any other device, unless the
number of patients in need of temperature management
exceeded the number of available cooling machines. In that
case the additional patients were cooled using conventional
cooling (considered standard cooling in our hospital) and not
included in this study. In each group, five patients were cooled
to hypothermia and five patients to normothermia.
Conventional cooling consisted of rapid infusion of 30 ml/kg
ideal bodyweight of lactated Ringer's solution at 4°C, followed
by surface cooling using ice and/or coldpacks. The timing and
amount of ice and coldpacks were judged by the attending
nurse and guided by the patient's temperature.
The water circulating cooling system consists of two water-cir-
culating cooling blankets, placed under and over the patient,
and a third smaller blanket under the patient's head. The large
blankets have of 1.1 m2 each, the smaller blanket a surface
area of 0.15 m2, and all are connected to an automatic temper-
ature control module guided by the rectal temperature of the
patient. The temperature of the water circulating through the
blankets ranges between 4°C and 42°C.
The air-circulating cooling system uses a single blanket placed
over the patient with a total surface area of 1.9 m2. According
to the manufacturer's manual, air temperature reaching the
patient is within 2°C of the listed temperatures, with an airflow
of 28–32 cfm. This blanket cannot be connected to an auto-
matically guided temperature module, and was set manually at
the lowest temperature possible (that is, 10°C). After the tar-
get temperature was reached, the temperature of the device
was manually adjusted by the attending nurse (range 10°C to
42°C).
The gel-coated external cooling device consists of four water
circulating gel coated energy transfer pads, and is placed on
the patient's back, abdomen, and both thighs. Depending on
the size used, the total surface area ranges between 0.60 and
0.77 m2. It is connected to an automatic thermostat controlling
the temperature of the circulating water (range 4°C to 42°C)
based on the patient's rectal temperature.
The intravascular cooling system uses a single lumen (8.5 Fr,
38 cm) central venous catheter inserted into the inferior vena
cava via the left or right femoral vein. Normal saline is pumped
through three balloons mounted on the catheter and returned
to a central system in a closed loop. The saline flow within the
balloons is in close contact with the patient's blood flow and
serves as a heat exchange system. An automatic temperature
control device adjusts the temperature of the circulating saline
(range 4°C to 42°C) based on the patient's rectal temperature.
Conventional cooling was the standard method of tempera-
ture control in the ICU. After extensive instruction by the man-
ufacturer, no learning curve was required for the different
cooling devices. All these cooling devices were used as
advised by the operator's manual and the distributor. None of
the commercially available systems were pre-cooled before
use. Temperature recording to measure cooling rate was
started when the cooling device was connected to the patientAvailable online http://ccforum.com/content/11/4/R91
Page 3 of 9
(page number not for citation purposes)
and ready for use. In the conventional group, time was started
at the start of the infusion of cold fluids. If the target tempera-
ture was not reached within 12 hours after start of the cooling,
ice and cold packs were used for additional cooling. No alter-
native cooling was used in the patients allocated to conven-
tional cooling.
Standard care
All patients were admitted to the ICU, monitored and treated
according to international standards. All patients were intu-
bated and mechanically ventilated. If necessary, patients were
sedated using midazolam and/or propofol to a Ramsay score
of 6 and received adequate analgesia with morphine or fenta-
nyl. If patients exhibited clinical signs of shivering they were
treated with extra sedation, morphine or rocuronium as a non-
depolarizing neuromuscular blocking agent. Use of paraceta-
mol was not dictated by protocol, but left to the discretion of
the attending medical staff. Vasoactive or inotropic support,
usually norepinephrine or dobutamine was administered if
necessary.
Data collection
Demographic, clinical, laboratory and pharmacological data
were obtained through review of the medical records of the
patients. Body temperature was measured continuously using
a rectal temperature probe (YSI Incorporated 401, Van de
Putte Medical, Nieuwegein, The Netherlands) and recorded
every 15 minutes for at least 24 hours. If the cooling device
was equipped with a temperature control module, the patients
received two separate rectal temperature probes, one con-
nected to the central ICU monitoring system, the other con-
nected to the control module of the cooling device.
The primary endpoints of the study were the initial rate of tem-
perature decrease, expressed as °C/h and the percentage of
time the temperature was out of range during the first 24 hours
of treatment (defined as more than 0.2°C above or below tar-
get temperature). When the temperature was out of range, the
mean temperature change from target was calculated. If the
target temperature was not reached within 24 hours, treat-
ment was considered as a failure.
Secondary endpoints of the study included occurrence of
overshoot cooling (defined as a temperature drop >0.5°C
below target temperature), incidence of hypotension (defined
as mean arterial pressure <60 mmHg) or arrhythmia, develop-
ment of skin lesions, and malfunction of the cooling device.
Infections were diagnosed using CDC criteria.
Statistical analysis
Power calculation was based on previous tests using the
water-circulating cooling device and conventional cooling with
ice and coldpacks. We considered a 20% difference in cool-
ing rate as clinically important. With an estimated standard
deviation (SD) of 15% and a significance level α of 0.05, a
sample size of 5 patients per group was calculated to reach a
power of 90%. We therefore included ten patients per group
in the present study (five patients in the hypothermia group
and five in the normothermia group). Rates of temperature
decline over time were analyzed with one-way analysis of vari-
ance. Differences between groups were analyzed with one-
way analysis of variance, with Bonferroni correction for multi-
ple comparisons or by Chi square test as appropriate. A p <
0.05 was considered statistically significant. All data are
expressed as mean ± SD unless otherwise stated.
Results
Baseline characteristics
A total of 50 patients were enrolled in the study. The clinical
and demographic characteristics of the patients at randomiza-
tion are shown in Table 1. No differences were found with
respect to age, body mass index, or APACHE II scores. The
majority of the patients treated with mild hypothermia were
patients after out-of-hospital arrest with a presumed cardiac
origin (Table 1). Other indications for hypothermia included in-
hospital-arrest, and uncontrollable intracranial pressure after
traumatic brain injury. The majority of the patients enrolled in
the normothermia group had subarachnoid hemorrhage or
traumatic brain injury (Table 1). Fever was most frequently of
infectious origin with pneumonia as the most frequent identi-
fied cause.
Induction of hypo- and normothermia
In the hypothermia group, the speed of cooling (expressed as
°C/h) was significantly higher in the patients cooled with the
water-circulating cooling device (1.33 ± 0.63°C/h), the gel-
coated external device (1.04 ± 0.14°C/h) and the intravascu-
lar catheter (1.46 ± 0.42°C/h) compared to both the air-circu-
lating cooling device (0.18 ± 0.20°C/h) and conventional
cooling (0.32 ± 0.24°C/h) (p < 0.05) (Figure 1). Similar results
were found in the normothermia group, with a mean tempera-
ture decrease of 1.12 ± 0.46°C/h in patients cooled with the
water-circulating cooling device, 1.02 ± 0.71°C/h with the gel-
coated device and 1.02 ± 0.55°C/h with the intravascular
catheter compared to both 0.15 ± 0.10°C/h with the air-circu-
lating cooling device and 0.06 ± 0.05°C/h with conventional
cooling (p < 0.05; Figure 1).
Additional cooling with ice and cold packs was necessary in
two patients in both the hypothermia and normothermia
groups cooled with the air-circulating cooling device (Table 2).
Treatment failure, defined as failure to reach the target temper-
ature within 24 hours after start of cooling, occurred in 2 hypo-
thermia patients with conventional cooling, 2 hypothermia
patients cooled with the air-circulating device, 4 normothermia
patients with conventional cooling and 1 normothermia patient
cooled with the air-circulating device. Use of sedatives and
analgesics differed (non-statistically) between groups (Table
2). Five patients were treated without the use of sedation.
These patients were comatose after cardiac arrest with aCritical Care    Vol 11 No 4    Hoedemaekers et al.
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Glasgow Coma Score of 3 and showed no signs of discomfort
or shivering while cooling to hypothermia (two patients) or nor-
mothermia (three patients). In the hypothermia group, neu-
romuscular blocking was necessary in two patients with
conventional cooling, three patients cooled with the air-circu-
lating and water-circulating systems, five patients cooled with
the gel-coated cooling device and five patients cooled with the
intravascular cooling system. In the normothermia group, neu-
romuscular blocking was used in no patients with conventional
cooling, three patients cooled with the air-circulating and
water-circulating systems, four patients cooled with the gel-
coated cooling device and five patients cooled with the intra-
vascular cooling system.
Maintaining hypo- and normothermia
After the target temperature was reached, we measured the
percentage of time the patient's temperature was 0.2°C below
or above the target temperature. Compared to all other cooling
methods, the intravascular cooling device was significantly
more reliable in keeping the patients within the target range
Table 1
Baseline characteristics of patients in the hypothermia and normothermia groups
Conventional BR CC AS CG P value
Hypothermia
Gender (male) 5 4 3 3 4 0.546
Age (years) 69.4 ± 16.3 64.6 ± 7.8 63.4 ± 17.6 58.8 ± 14.7 60.4 ± 14.6 0.706
APACHE II 26.8 ± 4.8 29.2 ± 5.2 22.4 ± 9.5 22.0 ± 11.8 26.2 ± 9.3 0.268
BMI (kg/m2) 26.3 ± 3.4 25.2 ± 1.5 26.0 ± 4.2 26.4 ± 3.8 24.4 ± 3.2 0.137
Diagnosis
OHA 2 4 3 5 2
IHA 2 0 0 0 2
Cardiac origin 2 3 3 3 2
High ICP 1 1 2 0 1
Alive at discharge from ICU 4 1 2 4 0 0.034
Normothermia
Gender (male) 3 4 4 3 5 0.546
Age (years) 46.4 ± 7.3 37.8 ± 14.7 49.0 ± 15.4 57.6 ± 16.2 48.8 ± 12.8 0.05
APACHE II 20.6 ± 7.9 15.6 ± 8.6 21.2 ± 9.6 24.2 ± 4.1 24.0 ± 7.3 0.770
BMI (kg/m2) 25.5 ± 0.5 25.9 ± 4.7 25.3 ± 2.8 25.7 ± 1.7 24.9 ± 1.8 0.868
Diagnosis
SAH 2 0 2 3 1
TBI 2 5 1 1 2
Post-anoxic 0 0 2 0 2
Intracerebral hemorrhage 1 0 0 1 0
Cause of fever
Pneumonia 3 3 3 5 2
Meningitis 1 1 0 0 0
CVC related bacteriemia 0 1 0 0 2
SIRS 1 0 2 0 1
Alive at discharge from ICU 5 3 0 4 5 0.003
Conventional, conventional cooling with ice cold fluids and ice/coldpacks; BR, water-circulating cooling system; CC, air-circulating cooling 
system; AS, gel-coated cooling system; CG, intravascular cooling system. BMI, body mass index; CVC, central venous catheter; ICP, intracranial 
pressure; ICU, intensive care unit; IHA, in-hospital arrest; OHA, out-of hospital arrest; SAH, sub-arachnoidal hemorrhage; SIRS, systemic 
inflammatory response syndrome; TBI, traumatic brain injury.Available online http://ccforum.com/content/11/4/R91
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(Figure 2). In the hypothermia group the intravascular catheter
was 3.2 ± 4.8% of the time out of range compared to 69.8 ±
37.6% with conventional cooling, 50.5 ± 35.9 with the water-
circulating cooling device, 74.1 ± 40.5% with the air-circulat-
ing cooling device and 44.2 ± 33.7% with the gel-coated
external cooling system (p < 0.05). Similar results were found
in the normothermia group: the intravascular catheter was 4.2
± 5.1% of the time out of range compared to 97.4 ± 5.8% with
conventional cooling, 74.8 ± 17.4 with the water-circulating
cooling device, 53.6 ± 29.5% with the air-circulating cooling
device and 40.2 ± 19.5% with the gel-coated external cooling
system (p < 0.05).
Mean temperature deviation from the target temperature in the
hypothermia group was significantly lower in the patients
cooled with the intravascular catheter (0.24 ± 0.14°C)
compared to all other groups: conventional cooling (0.48 ±
0.3°C), the water-circulating cooling device (0.58 ± 0.47°C),
the air-circulating cooling device (0.67 ± 0.36°C), and the gel-
coated external cooling system (0.45 ± 0.42°C) (Figure 3) (p
< 0.05). Mean temperature deviation from the target tempera-
ture in the normothermia group was significantly lower in
patients cooled with the intravascular catheter (0.13 ±
0.06°C) compared to conventional cooling (0.56 ± 0.38°C),
the water-circulating cooling device (0.66 ± 0.43°C), the air-
circulating cooling device (0.23 ± 0.18°C), and the gel-coated
external cooling system (0.31 ± 0.19°C) (Figure 3) (p < 0.05).
Adverse events
In the hypothermia group, a drop of body temperature during
initiation of cooling of more than 0.5°C below the target
temperature was found in 1 patient with conventional cooling,
3 patients cooled with the water-circulating cooling device
and 3 patients with the gel-coated external cooling device. In
the normothermia group, overshoot was found in three
patients cooled with the water-circulating cooling device and
two patients with the gel-coated external cooling device.
Hypotension and arrhythmia were observed only in hypother-
mia patients without differences between the groups (Table
2). This occurred exclusively in patients after cardiac arrest
and may have resulted from the underlying condition rather
than a specific cooling method. The use of inotropic agents
was comparable between the groups. Hypotension or use of
inotropic support was not related to speed of cooling or occur-
rence of overshoot cooling. Malfunctioning of a cooling device
did not occur. Skin lesions or catheter-related events, such as
thrombosis or infection, were not reported.
Discussion
This is the first study comparing the efficiency and safety of
five different cooling methods in inducing and maintaining
hypo- and normothermia in ICU patients. Cooling using water-
circulating blankets, gel-coated water circulating pads and
intravascular cooling was equally efficient in inducing hypo-
and normothermia. Intravascular cooling was superior to all
other cooling methods for maintaining a stable target temper-
ature. No adverse events related to a specific cooling method
were documented. The absence of adverse events should,
however, be interpreted with caution because of low numbers.
In our trial, induction of cooling using water-circulating blan-
kets, water-circulating gel pads or intravascular cooling was
equally effective. A previous comparison between water-circu-
lating blankets and gel pads in febrile ICU patients found that
cooling with gel pads was significantly more effective than
blankets in reducing fever [12]. This may be explained by the
fact that, in that trial, a single water blanket was used with a
surface area of only 0.92 m2. We used three water-circulating
cooling blankets with a total surface area of 2.35 m2. The rate
of cooling with the gel-pads in our trial is comparable with
results from previous trials [13,14], indicating that the perform-
ance of this cooling device was similar in our patients. Intravas-
cular cooling was equally effective in inducing the target
temperature compared to water blankets and gel pads. Previ-
ously, intravascular cooling has been shown to be more effec-
tive than air- and water-circulating blankets in both inducing
and maintaining hypothermia [15]. External cooling was signif-
icantly less efficient in our trial, possibly explaining the superi-
ority of the endovascular catheter in this study. The superiority
of endovascular cooling is most likely due to the direct heat-
exchange between catheter and blood, resulting in a rapid
transfer of cold blood through the body, whereas surface
cooling depends on relatively slow conduction of cold mainly
through the tissue itself. The effectiveness of devices with an
automatic temperature control module was higher compared
to manually operated methods. It is unlikely, however, that con-
Figure 1
Induction of hypo- and normothermia Induction of hypo- and normothermia. The pace of cooling (expressed 
as°C/h) in the hypothermia and normothermia groups. Bars represent 
mean values ± standard deviation. Asterisks indicate significant differ-
ences. Conventional, conventional cooling with ice cold fluids and ice/
coldpacks; BR, water-circulating cooling system; CC, air-circulating 
cooling system; AS, gel-coated cooling system; CG, intravascular cool-
ing system.Critical Care    Vol 11 No 4    Hoedemaekers et al.
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Table 2
Patient characteristics during cooling to hypo- and normothermia in the hypothermia and normothermia groups
Conventional BR CC AS CG P value
Hypothermia
S e d a t i v e s 5 5355 0 . 0 6 9
Neuromuscular blockers 2 3 3 5 5 0.129
A n a l g e s i c s 5 4355 0 . 1 9 5
P a r a c e t a m o l 3 0322 0 . 2 8 7
Inotropic agents 5 3 3 2 4 0.311
Vasodilatory agentsa 0 1301 0 . 1 1 2
Adverse events 0.271
Hypotensionb 2 2122
Arrhythmiac 0 2232
Skin lesions 0 0 0 0 0
Overshootd 0.058
N o .  o f  p a t i e n t s 1 3030
Lowest temperature (°C) 31.9 31.0 ± 0.3 32.4 ± 0.1
Use of additional cooling 0 0 2 0 0 0.069
Treatment failuree 2 0200 0 . 1 2 9
Normothermia
S e d a t i v e s 4 3555 0 . 1 9 5
Neuromuscular blockers 0 3 3 4 5 0.195
A n a l g e s i c s 4 3555 0 . 1 9 5
P a r a c e t a m o l 5 5445 0 . 5 1 5
Inotropic agents 1 0 2 3 2 0.311
Vasodilatory agentsa 0 0100 0 . 3 8 4
A n t i b i o t i c s 4 5555 0 . 3 8 4
Adverse events 0.069
Hypotensionb 0 0100
Arrhythmiac 0 0100
Skin lesions 0 0 0 0 0
Overshootd 0.040
N o .  o f  p a t i e n t s 0 3020
Lowest temperature (°C) 35.7 ± 0.4 36.1 ± 0.1
Use of additional cooling 0 0 2 0 0 0.069
Treatment failuree 4 0100 0 . 0 1 9
Conventional, conventional cooling with ice cold fluids and ice/coldpacks; BR, water-circulating cooling system; CC, air-circulating cooling 
system; AS, gel-coated cooling system; CG, intravascular cooling system. aVasodilatation used low dose nitroglycerin or ketanserin iv. 
bHypotension is defined as mean arterial pressure ≤ 60 mmHg. cArrhythmia defined as any rhythm but normal sinus rhythm, sinus bradycardia or 
sinus tachycardia. dOvershoot defined as drop of body temperature during initiation of cooling >0.5°C below target temperature. eTreatment 
failure defined as failure to reach target temperature within 24 hours after start of cooling.Available online http://ccforum.com/content/11/4/R91
Page 7 of 9
(page number not for citation purposes)
trol of temperature fully accounts for the lack of efficiency. At
the initiation of cooling all devices were set to their maximum
performance, yet the speed of cooling in the induction phase
was lower in the manually operated methods. In the case of
slow or inadequate regulation by the nursing staff, we would
have expected cases of severe hypothermia, which was not
the case in this series.
In terms of labour, the methods without an automatic temper-
ature feedback module required constant supervision by the
nursing staff and were most labour intensive. The endovascu-
lar method required the insertion of a central venous line; this
drawback is relative since most patients in the ICU need cen-
tral venous access under these conditions. The cost of the dif-
ferent devices is mainly determined by the use of the
disposables. The endovascular cooling system was most
expensive (approximately 1,000 Euro per patient) followed by
the gel coated surface cooling (approximately 700 Euro per
patient), the air circulating device (approximately 25 Euro per
patient) and the water circulating blanket (approximately 25
Euro per patient).
Conventional cooling was not effective in our study and
resulted in treatment failure in 60% of our patients. This is in
contrast with other studies showing an average temperature
decrease of 1.7°C to 2.5°C per hour [16-18]. An even higher
temperature decrease of 4°C in the first hour was found by
Polderman and colleagues [19], who combined ice-cold fluids
with a water-circulating cooling device. In our trial, conven-
tional cooling was induced by rapid infusion of 30 ml/kg ideal
bodyweight of lactated Ringer's solution at 4°C. The speed of
infusion was not dictated by protocol whereas in the study by
Polderman and colleagues, 1,500 ml of fluid was infused in 30
(no cardiac shock) or 60 minutes (cardiac shock). In addition,
Polderman and colleagues used water circulating blankets in
addition to the infusion of cold fluids. Application of ice or
coldpacks may have been less efficient compared to this cool-
ing device. The lack of effectiveness in our study may be the
result of slower infusion rates, lower volumes, or inadequate
amounts of ice and coldpacks.
Cooling was less efficient in normothermia compared to hypo-
thermia. At normothermia the body's control mechanisms to
maintain the centrally mandated target temperature are work-
ing at maximum efficiency. In addition, in hyperthermic
patients, the central thermostat may be influenced by inflam-
mation, or be deregulated by primary neurological damage. In
hypothermia the body's re-warming mechanisms are less
effective, especially when the body temperature drops below
33°C.
There are several limitations to this study. The nursing staff and
attending doctors could not be blinded to treatment allocation
for obvious practical reasons. It is unlikely that this would have
influenced the outcomes of this study since the cooling
devices were operated strictly according to the operators'
manuals, and temperatures were recorded automatically.
The use of sedatives, analgesics and neuromuscular blocking
agents differed between the groups. These drugs were admin-
istered only in case of shivering and distress, and their pre-
scription was left to the discretion of the attending medical
staff not involved in this clinical trial. In humans, core tempera-
ture is normally maintained within a tight range. A reference
temperature (set point) generated by a network of warm, cold,
Figure 2
Maintaining target temperature Maintaining target temperature. The ability of the cooling device to 
maintain a stable target temperature is depicted as the percentage of 
time the patient's temperature was 0.2°C below or above the target 
temperature. Bars represent mean values ± standard deviation. Aster-
isks indicate significant differences. Conventional, conventional cooling 
with ice cold fluids and ice/coldpacks; BR, water-circulating cooling 
system; CC, air-circulating cooling system; AS, gel-coated cooling sys-
tem; CG, intravascular cooling system.
Figure 3
Temperature deviation from target temperature Temperature deviation from target temperature. Mean temperature 
deviation after induction of hypothermia or normothermia while main-
taining the target temperature. Bars represent mean values ± standard 
deviation. Asterisks indicate significant differences. Conventional, con-
ventional cooling with ice cold fluids and ice/coldpacks; BR, water-cir-
culating cooling system; CC, air-circulating cooling system; AS, gel-
coated cooling system; CG, intravascular cooling system.Critical Care    Vol 11 No 4    Hoedemaekers et al.
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and thermal insensitive neurons in the pre-optic area is com-
pared with feedback from the skin and core thermoreceptors.
An error signal, proportional to the difference between the set
point and feedback signal, is generated, which activates ther-
moeffector pathways, including vasoconstriction and shiver-
ing. A larger difference between set point and feedback signal
will thus result in more intense vasoconstriction and shivering.
This was also the case in our trial: the devices that resulted in
a stronger decrease of the feedback signal induced shivering
more frequently. In this study, patients were sedated to a Ram-
say score of 6 and received adequate analgesia with morphine
or fentanyl. If patients exhibited clinical signs of shivering, they
were treated with extra sedation, morphine or muscle relaxa-
tion. In our ICU, this is the normal protocol in patients that need
temperature management. Most studies that compare differ-
ent cooling devices use a similar protocol of sedation and
relaxation [19-24]. In those studies as well as in our study,
patients treated with the most efficient cooling device needed
more sedation and relaxation. Since this was caused by the
stronger temperature decline in these patients, differences in
use of sedation and relaxation is considered a consequence
rather than cause of efficient cooling.
Pulmonary artery core temperature is considered the gold
standard for measurement of core body temperature [25-28].
A major disadvantage is the invasive nature of this technique
and its relatively high cost. Rectal temperature is comparable
to pulmonary artery core temperature (mean difference of 0.07
± 0.4°C) and has a time lag of approximately 15 minutes [29].
This technique was chosen because it is common practice in
most ICUs. In addition, the water-circulating cooling device,
the gel-coated external cooling system and the endovascular
cooling system are all equipped with an automatic tempera-
ture control device based on the patient's rectal temperature.
Previous studies comparing different devices also used non-
invasive temperature measurement. To ensure that the results
of this study are applicable to most ICUs and comparable to
previous studies, we chose to measure temperature in a non-
invasive way.
Conclusion
The results of our study demonstrate that water-circulating
blankets, gel-coated water circulating pads and intravascular
cooling are equally efficient in inducing hypothermia and nor-
mothermia. For maintaining the target temperature, intravascu-
lar cooling is superior to all other cooling methods.
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